Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

268.71

Today's Change

-7.295 (2.64%)

Day's Change

260.00 - 273.38

Trading Volume

151,074

Overview

Market Cap

5 Billion

Shares Outstanding

21 Million

Avg Volume

473,761

Avg Price (50 Days)

231.33

Avg Price (200 Days)

209.23

PE Ratio

-11.62

EPS

-23.13

Earnings Announcement

06-Aug-2024

Previous Close

276.01

Open

273.38

Day's Range

260.0 - 273.38

Year Range

119.76 - 299.98

Trading Volume

151,123

Price Change Highlight

1 Day Change

-2.64%

5 Day Change

-2.29%

1 Month Change

15.78%

3 Month Change

3.75%

6 Month Change

21.57%

Ytd Change

18.45%

1 Year Change

9.47%

3 Year Change

152.67%

5 Year Change

154.56%

10 Year Change

77.72%

Max Change

-15.54%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment